Electrophysiological Effects of Neurotensin on Globus Pallidus Neurons of 6-Hydroxydopamine-Lesioned Rats

被引:7
|
作者
Xue, Yan
Bai, Bo [2 ]
Yung, Wing-Ho [3 ]
Chen, Lei [1 ]
机构
[1] Qingdao Univ, Dept Physiol, Fac Med, Qingdao 266071, Peoples R China
[2] Jining Med Coll, Jining, Peoples R China
[3] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
基金
中国国家自然科学基金;
关键词
Globus pallidus; Neurotensin; 6-Hydroxydopamine; Parkinson's disease; Single unit recording; BINDING-SITE DENSITY; BASAL GANGLIA; SUBSTANTIA-NIGRA; PARKINSONS-DISEASE; IN-VIVO; FIRING PATTERNS; RECEPTOR; DOPAMINE; IMMUNOREACTIVITY; LESIONS;
D O I
10.1159/000199047
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The globus pallidus is a nucleus in the indirect pathway of the basal ganglia circuits. Neurotensin has been reported to play an important role in the central nervous system. Functional study revealed that systemic administration of neurotensin produced antiparkinsonian effects. The aim of the present study was to investigate the effects of neurotensin on the firing rate of globus pallidus neurons in 6-hydroxydopamine-lesioned parkinsonian rats. Micropressure ejection of neurotensin increased the spontaneous firing rate of globus pallidus neurons on both lesioned and unlesioned sides. Furthermore, the neurotensin-induced increase in firing rate on the unlesioned side (95.9%) was stronger than that on the lesioned side (37.3%). The neurotensin receptor antagonist, SR48692, prevented neurotensin-induced increase in firing rate. Based on the excitatory effects of neurotensin in globus pallidus of parkinsonian rats, we hypothesize that the pallidal neurotensinergic system may be involved in its possible therapy in Parkinson's disease. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:153 / 161
页数:9
相关论文
共 50 条
  • [31] Effects of Systemic Administration of Iptakalim on Extracellular Neurotransmitter Levels in the Striatum of Unilateral 6-Hydroxydopamine-Lesioned Rats
    Sen Wang
    Li-fang Hu
    Yun Zhang
    Tao Sun
    Ye-hong Sun
    Su-yi Liu
    Jian-hua Ding
    Jie Wu
    Gang Hu
    Neuropsychopharmacology, 2006, 31 : 933 - 940
  • [32] Morphological dendritic spine changes of medium spiny neurons in the nucleus accumbens in 6-hydroxydopamine-lesioned rats treated with levodopa
    Funamizu, Yukihisa
    Nishijima, Haruo
    Ueno, Tatsuya
    Ueno, Shinya
    Mizukami, Hiroki
    Yagihashi, Soroku
    Tomiyama, Masahiko
    NEUROSCIENCE RESEARCH, 2017, 121 : 49 - 53
  • [33] Blockade of globus pallidus adenosine A2A receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D1 or D2 dopamine receptor agonists
    Simola, Nicola
    Fenu, Sandro
    Baraldi, Pier G.
    Tabrizi, Mojgan Aghazadeh
    Morelli, Micaela
    SYNAPSE, 2008, 62 (05) : 345 - 351
  • [34] Protective effects of Hibiscus sabdariffa extracts in 6-hydroxydopamine-lesioned parkinsonism.
    Hamadjida, A.
    Otto, G. Ndji
    Kilekoung, M. K. Mingoas
    MOVEMENT DISORDERS, 2022, 37 : S312 - S313
  • [35] Hypertrophy of medial globus pallidus and substantia nigra reticulata in 6-hydroxydopamine-lesioned rats treated with L-DOPA: Implication for L-DOPA-induced dyskinesia in Parkinson's disease
    Tomiyama, M
    Mori, F
    Kimura, T
    Ichinohe, N
    Wakabayashi, K
    Matsunaga, M
    Baba, M
    NEUROPATHOLOGY, 2004, 24 (04) : 290 - 295
  • [36] ENHANCED ORAL ACTIVITY RESPONSE TO A77636 IN NEONATAL 6-HYDROXYDOPAMINE-LESIONED RATS
    HUANG, NY
    KOSTRZEWA, RM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 253 (1-2) : 163 - 166
  • [37] In vivo characterization of somatodendritic dopamine release in the substantia nigra of 6-hydroxydopamine-lesioned rats
    Sarre, S
    Yuan, H
    Jonkers, N
    Van Hemelrijck, A
    Ebinger, G
    Michotte, Y
    JOURNAL OF NEUROCHEMISTRY, 2004, 90 (01) : 29 - 39
  • [38] Entacapone increases and prolongs the central effects of levodopa in the 6-hydroxydopamine-lesioned rat
    Gerlach, M
    van den Buuse, M
    Blaha, C
    Bremen, D
    Riederer, P
    MOVEMENT DISORDERS, 2005, 20 : S100 - S100
  • [39] Intravenous hemantane improves levodopa-induced dyskinesias in in 6-hydroxydopamine-lesioned rats
    Valdman, E.
    Kokshenev, I.
    Kapitsa, I.
    Ivanova, E.
    Voronina, T.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 169 - 169
  • [40] Enhanced striatal glutamate release after the administration of rimonabant to 6-hydroxydopamine-lesioned rats
    Garcia-Arencibia, Moises
    Ferraro, Luca
    Tanganelli, Servio
    Fernandez-Ruiz, Javier
    NEUROSCIENCE LETTERS, 2008, 438 (01) : 10 - 13